<DOC>
	<DOCNO>NCT00335257</DOCNO>
	<brief_summary>The study compare short- long-term risk 24-day regimen drospirenone-containing oral contraceptive risk establish oral contraceptive study population representative actual user individual preparation .</brief_summary>
	<brief_title>International Active Surveillance Study Women Taking Oral Contraceptives ( INAS-OC )</brief_title>
	<detailed_description>Drospirenone novel progestogen antiandrogenic antimineralocorticoid property . A large active post-marketing surveillance study demonstrate 21-day regimen 3mg drospirenone 30mcg ethinylestradiol use safely oral contraception . This study investigate risk short long-term use 24-day regimen drospirenone/ethinylestradiol comparison establish OCs study population representative actual user individual preparation . INAS-OC prospective , control , non-interventional cohort study two study arm : OCs contain drospirenone OCs contain progestogen . The study start USA April 2005 extend several European country September 2008 base launch status 24-day regimen . New user OC ( starter , switcher without pill intake break recurrent user pill intake break [ different OC ] ) accrue network prescribe physician . Baseline follow-up information collect via self-administered questionnaire . Data analysis base life-table method compare cohort . All analysis make allowance confounding , use method include multivariate technique Cox regression .</detailed_description>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Firstever OC user ( `` starter '' ) Women switch OC use without pill intake break ( `` switcher '' ) Recurrent user pill intake break ( `` recurrent user '' ) Women willing participate active surveillance Women agree participate Longterm user</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Drospirenone</keyword>
	<keyword>Safety</keyword>
	<keyword>INAS</keyword>
</DOC>